optic neuropathy semaglutide Last month, the European Medicines Agency recommended that product information for #semaglutide medicines— the active ingredient in #Ozempic, #Rybelsus, and #Wegovy — be updated to include non-arteritic anterior ischemic or # Semaglutide linked to risk of

Cardiovascular Benefits: GLP-1 drugs may offer additional protection against heart disease, a crucial consideration for psoriasis and PsA patients

These injectables often cause temporary side effects and may resolve after a few days or a week

Inject the second syringe at a different site, such as the right side of the abdomen

Vascular damage is evident as a loss of tight junction proteins on endothelial cells, an increase of permeability and the detachment of astrocytes and pericytes (Figure 1) Dysregulation contributes to cerebrovascular accidents, generates inflammation, and is linked to neurodegenerative diseases, epilepsies, and neuroinflammatory disorders, including multiple sclerosis (Engelhardt and Ransohoff, 2011

In a medically supervised, quality-controlled context with appropriate screening and protocol design, it is generally viewed as a reasonable regenerative strategy and is commonly reported as well tolerated

Cardiovascular outcome studies including LEADER and SUSTAIN-6 confirmed that GLP-1 medications reduce heart attack and stroke risk in people with established type 2 diabetes, an effect that persists when patients concurrently use metformin